abstract |
The present invention relates to an antibody binding specifically to a peptide of sequence number 1, and, more specifically, relates to: an antibody binding specifically to an isolated peptide of sequence number 1, or a binding fragment of the peptide; a polynucleotide coding for the antibody or the binding fragment of the peptide; a vector comprising the polynucleotide; cells into which the vector has been introduced; a production method for the antibody or the binding fragment of the peptide, using the cells; the antibody or binding fragment of the peptide produced by means of the production method; an antiviral composition comprising the antibody or binding fragment of the peptide; a composition for preventing or treating inflammatory disease, the composition comprising the antibody or the binding fragment of the peptide; and a treatment method for a viral infection, or a treatment method for inflammatory disease, using the composition. |